Imbio RV/LV Software vs ClearRead CT
AI Verdict
Choose Imbio RV/LV Software if…
Choose Imbio RV/LV Software if your primary need is automated, AI-driven measurement of right and left ventricular diameters from CTPA scans. This tool is ideal for rapid risk stratification of patients with suspected pulmonary conditions, such as pulmonary embolism, by providing a crucial RV/LV ratio. Its fully automated workflow and integration with standard reading environments streamline the assessment of cardiac strain.
View Imbio RV/LV Software →Choose ClearRead CT if…
Choose ClearRead CT if your focus is on enhancing the detection and characterization of pulmonary nodules and performing coronary artery calcification scoring from CT scans. This AI suite is best suited for improving diagnostic accuracy, reducing reading times, and streamlining workflows in general cardiothoracic radiology. Its patented vessel suppression technology and automated nodule tracking provide comprehensive support for lung cancer screening and cardiac risk assessment.
View ClearRead CT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio RV/LV Software | ClearRead CT |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27] | On-premise (stand-alone server, virtual machine) and Cloud |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Imbio RV/LV SoftwareTool A (Imbio RV/LV Software) emphasizes a 'fully automated workflow, no user intervention required after scan completion,' which suggests a highly streamlined and easy-to-use experience once integrated. While Tool B (ClearRead CT) also offers seamless PACS integration and reduced reading times, Tool A's explicit mention of zero post-scan intervention gives it a slight edge in pure automation and ease of use.
Clinical Value
ClearRead CTTool B (ClearRead CT) offers broader clinical value by enhancing pulmonary nodule detection and coronary artery calcification analysis, with a quantifiable claim of '29% reduction in missed actionable nodules.' While Tool A (Imbio RV/LV Software) provides crucial risk stratification for pulmonary embolism, Tool B's impact spans both oncology and cardiology with a clear, measurable improvement in diagnostic accuracy for a wider range of critical findings.
Pricing & Value
Imbio RV/LV SoftwareTool A (Imbio RV/LV Software) offers a more transparent 'subscription-based' pricing model, with costs determined by the 'number of analyses, number of installations.' This allows potential customers to better understand and estimate their investment. Tool B (ClearRead CT) requires contacting the vendor for pricing details, which can make initial value assessment less straightforward.
Enterprise Readiness
Imbio RV/LV SoftwareTool A (Imbio RV/LV Software) demonstrates superior enterprise readiness through its diverse deployment options, including cloud, on-premise (VMware), and integration with numerous partner platforms (e.g., Nuance, Aidoc, Siemens Syngo.via). Furthermore, it explicitly states 'yes, third-party hipaa compliant certified by compliancy group' and 'has_baa: yes (implied by hipaa compliance),' offering stronger assurances for large-scale healthcare environments compared to Tool B's 'likely' status for HIPAA and BAA.
Innovation
ClearRead CTTool B (ClearRead CT) showcases more distinct technological innovation with its 'Patented Vessel Suppression (Clear Visual Intelligence)' and 'Automated Nodule Tracking and Comparison to Prior Exams.' These features represent advanced capabilities in image processing and longitudinal patient management. While Tool A (Imbio RV/LV Software) leverages AI for automated measurements, Tool B's specific patented technology and tracking capabilities appear to be more groundbreaking.
Support & Docs
TieBoth Imbio and Riverain Technologies (ClearRead CT) offer customer support channels including phone and email, and provide access to documentation like user manuals. Imbio explicitly states 24/7/365 support for email and website tickets. Riverain Technologies also provides a customer success hotline and resources like FAQs, system requirements, and manuals. Without more detailed, comparative information on the quality, responsiveness, or comprehensiveness of their respective support and documentation, it is difficult to definitively declare a winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio RV/LV Software | ClearRead CT |
|---|---|---|
| Name | Imbio RV/LV Software | ClearRead CT |
| Company | Imbio | RIVERAIN TECHNOLOGIES |
| Primary Focus | Automatically measures right and left ventricular diameters from CTPA scans, providing a ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism. | Enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans. |
| Key Feature: Ventricular Measurement | Automated measurement of right and left ventricular diameters and calculation of RV/LV ratio. | Not specified |
| Key Feature: Nodule Detection | Not specified | Pulmonary Nodule Detection (solid, part-solid, ground glass) and Nodule Characterization and Measurement. |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Pulmonology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Imbio RV/LV Software and ClearRead CT.